Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole

Annals of Pharmacotherapy

Volumn 40, Issue 11, 2006, Pages 2059-2063

  Vilchez, Francisco J ^a   Torres, Isabel ^a   Garcia Valero, Amor ^a   López Tinoco, Cristina ^a   De Los Santos, Alberto ^a   Aguilar Diosdado, Manuel ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Agranulocytosis; Carbimazole; Hepatotoxicity

Indexed keywords

CARBIMAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IODINE; IODINE 131; LIOTHYRONINE; PROPRANOLOL; THYROID ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE;

ACHOLIA; ACHOLURIA; ADULT; AGRANULOCYTOSIS; ANOREXIA; ARTHRALGIA; ARTICLE; ASTHENIA; BONE MARROW BIOPSY; BONE MARROW TOXICITY; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; DISEASE SEVERITY; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; FEVER; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; JAUNDICE; LIVER TOXICITY; NARANJO PROBABILITY SCALE; NERVOUSNESS; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PROBABILITY; PRURITUS; RASH; RATING SCALE; SYMPTOM; TACHYCARDIA; URTICARIA; WEIGHT REDUCTION;

ADULT; AGRANULOCYTOSIS; CARBIMAZOLE; FEMALE; HEPATITIS, TOXIC; HUMANS;

EID: 33750977868     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G720     Document Type: Article

References (25)

1. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-17.
2. Pearce SHS. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf) 2004;61:589-94.
3. Nakashima T, Taurog A. Rapid conversion of carbimazole to methimazole in serum: evidence for an enzymatic mechanism. Clin Endocrinol (Oxf) 1979;10:637-48.
4. Skellern GG, Knight BI, Low CK, Alexander WD, McLarty DG, Kalk WJ. The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole in hyperthyroid patients. Br J Clin Pharmacol 1980;9:137-43.
5. Kampmann JP, Hansen JM. Clinical pharmacokinetics of antithyroid drugs. Clin Pharmacokinet 1981;6:401-28.
6. Streetman DD, Khanderia U. Diagnosis and treatment of Graves' disease. Ann Pharmacother 2003;37:1100-9. DOI 10.1345/aph.1C299
7. Tajiri J, Noguchi S, Murakami Y. Murakami N. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Ann Intern Med 1990;150:621-4.
8. Woeber KA. The year in review: the thyroid. Ann Intern Med 1999;131:959-62.
9. Kenneth A, Woeber MD. Methimazole-induced hepatotoxicity. Endocr Pract 2002;8:222-4.
10. Cooper DS. Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's the thyroid. 8th ed. Philadelphia: Lippincott Williams and Wilkins, 2000:691-715.
11. Shiroozu A, Okamura K, Ikenoue H, et al. Treatment of hyperthyroidism with a small single dose of methimazole. J Clin Endocrinol Metab 1986;63:125-8.
12. Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS. Adverse effects related to thionamide drugs and their dose regimen. Am J Med Sci 1989;297:216-9.
13. Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs. Ann Intern Med 1983;98:26-9.
14. Meyer-Gessner M, Benker S, Lederbogen S, Olbicht T, Reinwein D. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocr Invest 1994;17:29-36.
15. Julia A, Olona M, Bueno J, et al. Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol 1991;79:366-71.
16. Toth EL, Mant MJ, Shivji S, Ginsberg J. Propylthiouracil-induced agranulocytosis: an unusual presentation and a possible mechanism. Am J Med 1988;85:725-7.
17. Akamizu T, Ozaki S, Hiratani H, et al. Drug-induced neutropenia associated with antineutrophil cytoplasmic antibodies (ANCA): possible involvement in granulocyte cytotoxicity. Clin Exp Inmunol 2002;127:92-8.
18. Fukata S, Kuma K, Sugawara M. Granulocyte colony-stimulating factor (GCSF) doesn't improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 1999;9:29-31.
19. Andres E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel E. Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis. QJM 2001;94:423-8.
20. Cooper DS. The side effects of antithyroid drugs. Endocrinologist 1999;9:457-76.
21. Williams KV, Natak S, Becker D, Reyes J, Burmeister LA. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab 1997;82:1727-33.
22. Ruiz JK, Rossi GV, Vallejos HA, Brenet RW, Lopez IB, Escribano AA. Fulminant hepatic failure associated with propylthiouracil. Ann Pharmacother 2003;37:224-8. DOI 10.1345/aph.1A408
23. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004;10:1018-23.
24. Arab DM, Malatjalian DA, Rittmaster RS. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J Clin Endocrinol Metab 1995;80:1083-5.
25. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.